Asthma drugs in kids may be restricted

The draft report of the PBS post-market review of medications used to treat asthma in children found nearly 80% of prescriptions for FDC inhalers were for first-line treatment, and therefore outside PBS restrictions because they are recommended for second-line therapy.

More than 25% of FDC prescriptions were supplied to children younger than five years, a contravention of national guidelines.

A large number of children (59—79%) with no prior inhaled corticosteroid (ICS) use had only one FDC